REMEDI Programme Manager
Kieran is responsible for coordinating and managing activities at REMEDI. This includes intellectual property management, graduate study programmes, financial management and outreach programmes.
Development of human artificial chromosomes for gene therapy in induced pluripotent stem cells.
Mikey's research is in examining the role of modified human endothelial progenitor cells and mesenchynal stem cells in the treatment of cardiovasuclar disease.
Characterisation of novel biomarkers for schizophrenia.
Professor of Zoology
Developmental Biology, Stem Cells in animals and marine organisms, the manipulation of key stem cells and their derivatives
Scientific Director of REMEDI
The therapeutic application of adult stem cells, especially mesenchymal stem cells (MSCs) from bone marrow.
Cardiovasular, Mesenchymal Stem Cells (MSCs), Angiogenic potential of microencapsulated MSCs
Bairbre's research is focusing on diabetic kidney disease (diabetic nephrology), in particular looking at approaches used in vivo animal and human studies.
Lecturer in Zoology
Gene therapy, Mesenchymal stem cells
Siti's research is investigating the mechanism of mesenchymal stem cells (MSCs) in mediated cardiac repair
Consultant Endocrinologist, Galway University Hospitals
Interests are delivering programmes of self-management education for people with diabetes and developing optimal models of community-based diabetes care.
Roisin investigates the potential of human MSCs as vectors for therapeutic gene delivery to breast tumor tissue